Dr. Otterson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 W 10th Ave
Columbus, OH 43210Phone+1 614-293-6529Fax+1 614-293-9469
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1989 - 1992
Rush University Medical CenterResidency, Internal Medicine, 1986 - 1989
Georgetown University School of MedicineClass of 1986
Certifications & Licensure
OH State Medical License 1998 - 2024
MD State Medical License 1989 - 1999
IL State Medical License 1986 - 1990- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACP) American College of Physicians, 2002
- Join now to see all
Clinical Trials
- Capecitabine in Treating Patients With Malignant Mesothelioma Start of enrollment: 2000 Nov 01
- Combination Chemotherapy in Treating Patients With Solid Tumors Start of enrollment: 2001 Jan 01
- Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer Start of enrollment: 2004 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 35 citationsA Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung CancerAlberto Chiappori, Gregory A. Otterson, Afshin Dowlati, Anne M. Traynor, Leora Horn
The Oncologist. 2016-10-01 - 2 citationsAssociation Between Pretreatment Chest Imaging and Immune Checkpoint Inhibitor Pneumonitis Among Patients With Lung Cancer.Alexander Wong, Maria Riley, Songzhu Zhao, Jessica Zimmer, Matthew Viveiros
Journal of the National Comprehensive Cancer Network. 2023-11-01 - 158 citationsFirst-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 TrialLuis Paz-Ares, Suresh S. Ramalingam, Tudor-Eliade Ciuleanu, Jong Seok Lee, László Urbán
Journal of Thoracic Oncology. 2021-10-12
Journal Articles
- Identifying Patterns of Care for Elderly Patients with Non-Surgically Treated Stage III Non-Small Cell Lung Cancer: An Analysis of the National Cancer DatabaseKai He, Terence M Williams, John C Grecula, Eric D Miller, Erin M Bertino, David P Carbone, Peter G Shields, Jose G Bazan, Karl E Haglund, Gregory A Otterson, BioMed Central
Press Mentions
Targeted Therapy of Lung Cancer – Lung Cancer Targeted TherapyOctober 28th, 2015
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
